Literature DB >> 1681744

Progesterone and modulation of endothelium-dependent responses in canine coronary arteries.

V M Miller1, P M Vanhoutte.   

Abstract

Chronic treatment with estrogens enhances some endothelium-dependent relaxations. Whether or not progesterone would exert a similar effect is unknown. Experiments were designed to determine the effect of chronic treatment with progesterone on endothelium-dependent responses. Adult female dogs were ovariectomized and pellets containing carrier substance, estrogen, progesterone, or estrogen plus progesterone were implanted subcutaneously. After 14-21 days coronary arteries were removed, cut into rings, and suspended for the measurement of isometric force in organ chambers in the presence of indomethacin. Endothelium-dependent relaxations to ADP, bradykinin, or the calcium ionophore did not differ among groups. However, relaxations to acetylcholine and to the alpha 2-adrenergic agonist BHT-920 were greater in the estrogen-treated group than in the estrogen plus progesterone-treated group. In rings without endothelium, relaxations to nitric oxide and isoproterenol did not differ among groups. However, relaxations of the smooth muscle to ADP were greater in the progesterone-treated group than in the progesterone plus estrogen group. These results suggest that progesterone alone minimally affects endothelium-dependent responses. However, progesterone seems to antagonize the stimulatory effects of estrogen on two endothelium-dependent responses that are associated with pertussis toxin-sensitive guanine nucleotide regulatory proteins and the production of nitric oxide. These studies suggest that a specific receptor/second messenger system can be modulated by female reproductive steroid hormones.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1681744     DOI: 10.1152/ajpregu.1991.261.4.R1022

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  25 in total

Review 1.  Management of lipid disorders in the elderly.

Authors:  D A Playford; G F Watts
Journal:  Drugs Aging       Date:  1997-06       Impact factor: 3.923

2.  Nitric oxide contributes to estrogen-induced vasodilation of the ovine uterine circulation.

Authors:  C R Rosenfeld; B E Cox; T Roy; R R Magness
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

3.  Induction of calcium-dependent nitric oxide synthases by sex hormones.

Authors:  C P Weiner; I Lizasoain; S A Baylis; R G Knowles; I G Charles; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

4.  Phase of the menstrual cycle does not affect orthostatic tolerance in healthy women.

Authors:  Victoria Elizabeth Claydon; Nabeela Raheena Younis; Roger Hainsworth
Journal:  Clin Auton Res       Date:  2006-04       Impact factor: 4.435

5.  Bazedoxifene-induced vasodilation and inhibition of vasoconstriction is significantly greater than estradiol.

Authors:  Margaret A Zimmerman; Dillion D Hutson; Franck Mauvais-Jarvis; Sarah H Lindsey
Journal:  Menopause       Date:  2019-02       Impact factor: 2.953

6.  Implications of estradiol and progesterone in pulmonary vasodilatation in cirrhotic patients.

Authors:  R Aller; J L Moya; S Avila; J Villa; V Moreira; R Bárcena; D Boxeida; D A de Luis
Journal:  J Endocrinol Invest       Date:  2002-01       Impact factor: 4.256

7.  Sexual dimorphism in rat aortic endothelial function of streptozotocin-induced diabetes: possible involvement of superoxide and nitric oxide production.

Authors:  Xiaoyuan Han; Rui Zhang; Leigh Anderson; Roshanak Rahimian
Journal:  Eur J Pharmacol       Date:  2013-11-06       Impact factor: 4.432

Review 8.  Cellular signaling and NO production.

Authors:  Thomas Michel; Paul M Vanhoutte
Journal:  Pflugers Arch       Date:  2010-01-16       Impact factor: 3.657

9.  Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice.

Authors:  P A Bourassa; P M Milos; B J Gaynor; J L Breslow; R J Aiello
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

10.  Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS).

Authors:  V M Miller; D M Black; E A Brinton; M J Budoff; M I Cedars; H N Hodis; R A Lobo; J E Manson; G R Merriam; F Naftolin; N Santoro; H S Taylor; S M Harman
Journal:  J Cardiovasc Transl Res       Date:  2009-05-22       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.